065170 — BL PharmTech Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro CapSucker Stock

Market Cap
KR₩19bn
Enterprise Value
KR₩21bn
Revenue
KR₩9bn

Annual balance sheet for BL PharmTech, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	12,380	22,752	5,524	10,687	3,864
Net Total Accounts Receivable
Net Total Receivables	10,630	11,182	11,143	1,104	1,039
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	36,456	42,301	32,612	16,915	6,937
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	48,512	42,899	42,339	2,878	4,129
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	134,325	130,341	103,687	44,802	36,458
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	31,731	37,000	48,979	7,965	6,629
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	68,224	71,845	69,886	13,383	12,211
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	66,102	58,497	33,800	31,419	24,247
Total Liabilities & Shareholders' Equity	134,325	130,341	103,687	44,802	36,458
Total Common Shares Outstanding